Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A never-ending FLT3 story.
Kiyoi H. Kiyoi H. Nagoya J Med Sci. 2023 Feb;85(1):27-29. doi: 10.18999/nagjms.85.1.27. Nagoya J Med Sci. 2023. PMID: 36923638 Free PMC article. No abstract available.
Rhof promotes murine marginal zone B cell development.
Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, Takagi A, Ikawa M, Kojima T, Kunishima S, Kiyoi H, Naoe T, Matsushita T, Maruyama M. Kishimoto M, et al. Among authors: kiyoi h. Nagoya J Med Sci. 2014 Aug;76(3-4):293-305. Nagoya J Med Sci. 2014. PMID: 25741038 Free PMC article.
Myh9 R702C is associated with erythroid abnormality with splenomegaly in mice.
Kanematsu T, Suzuki N, Tamura S, Suzuki A, Ishikawa Y, Katsumi A, Kiyoi H, Saito H, Kunishima S, Kojima T, Matsushita T. Kanematsu T, et al. Among authors: kiyoi h. Nagoya J Med Sci. 2021 Feb;83(1):75-86. doi: 10.18999/nagjms.83.1.75. Nagoya J Med Sci. 2021. PMID: 33727739 Free PMC article.
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study.
Kawashima N, Ishikawa Y, Atsuta Y, Sawa M, Ozawa Y, Hayashi M, Kohno A, Tomita A, Maeda T, Sakaida E, Usuki K, Hagihara M, Kanamori H, Matsuoka H, Kobayashi M, Asou N, Ohtake S, Matsumura I, Miyazaki Y, Naoe T, Kiyoi H; Japan Adult Leukemia Study Group (JALSG). Kawashima N, et al. Among authors: kiyoi h. Cancer Sci. 2020 Jul;111(7):2472-2481. doi: 10.1111/cas.14448. Epub 2020 May 29. Cancer Sci. 2020. PMID: 32391628 Free PMC article. Clinical Trial.
FLT3 in human hematologic malignancies.
Kiyoi H, Naoe T. Kiyoi H, et al. Leuk Lymphoma. 2002 Aug;43(8):1541-7. doi: 10.1080/1042819021000002866. Leuk Lymphoma. 2002. PMID: 12400596 Review.
Normal and oncogenic FLT3.
Naoe T, Kiyoi H. Naoe T, et al. Among authors: kiyoi h. Cell Mol Life Sci. 2004 Dec;61(23):2932-8. doi: 10.1007/s00018-004-4274-x. Cell Mol Life Sci. 2004. PMID: 15583855 Review.
Clinical significance of FLT3 in leukemia.
Kiyoi H, Yanada M, Ozekia K. Kiyoi H, et al. Int J Hematol. 2005 Aug;82(2):85-92. doi: 10.1532/IJH97.05066. Int J Hematol. 2005. PMID: 16146837 Review.
FLT3 mutations in acute myeloid leukemia.
Kiyoi H, Naoe T. Kiyoi H, et al. Methods Mol Med. 2006;125:189-97. doi: 10.1385/1-59745-017-0:189. Methods Mol Med. 2006. PMID: 16502586
314 results